Unknown

Dataset Information

0

Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report.


ABSTRACT: Resistance to thyroid hormone beta (RTH?) is a rare and usually dominantly inherited syndrome caused by mutations of the thyroid hormone receptor ? gene (THRB). In severe cases, it is rarely challenging to control manifestations using daily therapeutic replacement of thyroid hormone.The present case study concerns an 8-year-old Japanese girl with a severe phenotype of RTH (TSH, fT3, and fT4 were 34.0 mU/L, >25.0 pg/mL and, >8.0 ng/dL, respectively), caused by a novel heterozygous frameshift mutation in exon 10 of the thyroid hormone receptor beta gene (THRB), c.1347-1357 del actcttccccc : p.E449DfsX11. RTH was detected at the neonatal screening program. At 4 years of age, the patient continued to suffer from mental retardation, hyperactivity, insomnia, and reduced resting energy expenditure (REE), despite daily thyroxine (L-T4) therapy. Every-other-day high-dose liothyronine (L-T3) therapy improved her symptoms and increased her REE, without thyrotoxicosis.In a case of severe RTH, every-other-day L-T3 administration enhanced REE and psychomotor development, without promoting symptoms of thyrotoxicosis. Every-other-day L-T3 administration may be an effective strategy for the treatment of severe RTH.

SUBMITTER: Maruo Y 

PROVIDER: S-EPMC4709977 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report.

Maruo Yoshihiro Y   Mori Asami A   Morioka Yoriko Y   Sawai Chihiro C   Mimura Yu Y   Matui Katsuyuki K   Takeuchi Yoshihiro Y  

BMC endocrine disorders 20160112


<h4>Background</h4>Resistance to thyroid hormone beta (RTHβ) is a rare and usually dominantly inherited syndrome caused by mutations of the thyroid hormone receptor β gene (THRB). In severe cases, it is rarely challenging to control manifestations using daily therapeutic replacement of thyroid hormone.<h4>Case presentation</h4>The present case study concerns an 8-year-old Japanese girl with a severe phenotype of RTH (TSH, fT3, and fT4 were 34.0 mU/L, >25.0 pg/mL and, >8.0 ng/dL, respectively), c  ...[more]

Similar Datasets

| S-EPMC10145980 | biostudies-literature
| S-EPMC7598850 | biostudies-literature
| S-EPMC6797074 | biostudies-literature
| S-EPMC3868256 | biostudies-literature
| S-EPMC3047217 | biostudies-literature
| S-EPMC4738189 | biostudies-literature
| S-EPMC6550962 | biostudies-literature
| S-EPMC3687625 | biostudies-literature
| S-EPMC5370793 | biostudies-literature